We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+38.04%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$2.87B
AUM Growth
+$618M
Cap. Flow
+$28.8M
Cap. Flow %
1%
Top 10 Hldgs %
19.2%
Holding
366
New
53
Increased
96
Reduced
56
Closed
140

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$25.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$19.8M
4
ALGM icon
Allegro MicroSystems
ALGM
+$18M
5
OCUL icon
Ocular Therapeutix
OCUL
+$16.7M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$40.5M
2
BLD
TopBuild
BLD
+$35.6M
3
TWST icon
Twist Bioscience
TWST
+$28.1M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$23.3M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 22.68%
2 Technology 19.33%
3 Consumer Discretionary 14.56%
4 Industrials 13.15%
5 Financials 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATAC.U
126
DELISTED
Altimar Acquisition Corp Units
ATAC.U
$3.96M 0.14%
+328,500
New +$3.46M
HYFM icon
127
Hydrofarm Holdings
HYFM
$7.62M
$3.77M 0.13%
+7,171
New +$3.75M
PYPL icon
128
PayPal
PYPL
$50.5B
$3.67M 0.13%
15,669
+13,759
+720% +$2.85M
PASG icon
129
Passage Bio
PASG
$14.1M
$3.53M 0.12%
6,908
-9,436
-58% -$3.78M
CRDF icon
130
Cardiff Oncology
CRDF
$77.2M
$3.47M 0.12%
193,133
-140,374
-42% -$2.47M
SFBS
131
ServisFirst Bancshares
SFBS
$4.86B
$3.37M 0.12%
83,618
– –
TRIT
132
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
$3.31M 0.12%
300,440
+244,340
+436% +$2.85M
BFT.U
133
DELISTED
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
$3.2M 0.11%
+188,249
New +$2.24M
TSC
134
DELISTED
TriState Capital Holdings, Inc.
TSC
$3M 0.1%
172,495
-68,480
-28% -$1.03M
LPRO
135
DELISTED
Open Lending Corp
LPRO
$2.98M 0.1%
85,272
-97,130
-53% -$2.82M
NREF
136
NexPoint Real Estate Finance
NREF
$342M
$2.92M 0.1%
176,443
-1,402
-0.8% -$21.9K
ALLY icon
137
Ally Financial
ALLY
$13.3B
$2.91M 0.1%
81,700
– –
MDWT
138
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$2.85M 0.1%
+53,034
New +$3.06M
IIPR icon
139
Innovative Industrial Properties
IIPR
$1.72B
$2.73M 0.1%
14,920
+14,669
+5,844% +$2.2M
EQOS
140
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$2.67M 0.09%
+165,280
New +$1.36M
LIND icon
141
Lindblad Expeditions
LIND
$2.22B
$2.59M 0.09%
+151,508
New +$1.74M
LEAF
142
DELISTED
Leaf Group Ltd.
LEAF
$2.44M 0.08%
+525,000
New +$2.89M
FCBP
143
DELISTED
First Choice Bancorp Common Stock
FCBP
$2.43M 0.08%
131,419
+8,917
+7% +$141K
PSTL
144
Postal Realty Trust
PSTL
$699M
$2.26M 0.08%
134,007
-2,170
-2% -$33.6K
OYST
145
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$2.23M 0.08%
118,715
-222,568
-65% -$4.8M
PW
146
Power REIT
PW
$2.84M
$2.23M 0.08%
+8,362
New +$2.05M
AMTBB
147
DELISTED
Amerant Bancorp Inc. Class B Common Stock
AMTBB
$2.22M 0.08%
190,534
– –
AGNT
148
AGNT Inc
AGNT
$734M
$1.91M 0.07%
+60,420
New +$1.67M
MILE
149
DELISTED
Metromile, Inc. Common Stock
MILE
$1.9M 0.07%
+122,370
New +$1.64M
HASI icon
150
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
$1.82M 0.06%
28,680
+12,470
+77% +$637K
4 5
6
7 8

Similar funds

SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
YC
Yarbrough Capital Franklin, Tennessee $2.85B AUM 36.22% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Mutual Fund Advisers Trust held 366 positions worth $2.87B, up 27% from $2.26B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q4 2020 filing shows 53 new, 96 increased, 56 reduced and 140 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 218,390 shares worth $30.2M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $40.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Mutual Fund Advisers Trust's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 218,390 shares worth $30.2M.
  • Emerald Mutual Fund Advisers Trust added most to Houlihan Lokey in Q4 2020, an estimated $15.8M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $40.5M.
  • Emerald Mutual Fund Advisers Trust fully exited QTS REALTY TRUST, INC. in Q4 2020, selling an estimated $23.3M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 19% of its $2.87B portfolio in Q4 2020.
  • Emerald Mutual Fund Advisers Trust opened 53 new positions and closed 140 in Q4 2020.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 27% quarter-over-quarter to $2.87B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2020, filed 29 Jan 2021.